The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
An investigation into the human serum “interactome”
Abstract
The protein content of human serum is composed of a millieu of proteins from almost every type of cell and tissue within the body. The serum proteome has been shown to contain information that directly reflects pathophysiological states and represents an invaluable source of diagnostic information for a variety of different diseases. Unfortunately, the dynamic range of protein abundance, ranging from ≫ mg/mL level to ≪ pg/mL level, renders complete characterization of this proteome nearly impossible with current analytical methods. To study low‐abundance proteins, which have potential value for clinical diagnosis, the high‐abundant species, such as immunoglobulins and albumin, are generally eliminated as the first step in many analytical protocols. This step, however, is hypothesized to concomitantly remove proteins/peptides associated with the high‐abundant proteins targeted for depletion. In this study, immunoprecipitation was combined with microcapillary reversed‐phase liquid chromatography (μRPLC) coupled on‐line with tandem mass spectrometry (MS/MS) to investigate the low‐molecular‐weight proteins/peptides that associate with the most abundant species in serum. By this targeted isolation of select highly abundant serum proteins, the associated proteins/peptides can be enriched and effectively identified by μRPLC‐MS/MS. Among the 210 proteins identified, 73% and 67% were not found in previous studies of the low‐molecular‐weight or whole‐serum proteome, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Self-citationLi, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., & Chan, D. W. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1296 · Cited by 893
Characterization of the Low Molecular Weight Human Serum Proteome
Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J., Conrads, T. P., & Veenstra, T. D. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300031-mcp200 · Cited by 860
Self-citationToward a Human Blood Serum Proteome
Adkins, J. N., Varnum, S. M., Auberry, K. J., Moore, R. J., Angell, N. H., Smith, R. D., Springer, D. L., & Pounds, J. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200066-mcp200 · Cited by 793
Serum Proteomic Patterns for Detection of Prostate Cancer
Petricoin, E. F. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1576 · Cited by 736
Self-citationBiology of Prostate-Specific Antigen
Balk, S. P., Ko, Y.-J., & Bubley, G. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.083 · Cited by 718
Pieper, R., Gatlin, C. L., Makusky, A. J., Russo, P. S., Schatz, C. R., Miller, S. S., Su, Q., McGrath, A. M., Estock, M. A., Parmar, P. P., et al. (2003) · PROTEOMICS · doi:10.1002/pmic.200300449 · Cited by 518
Qu, Y., Adam, B.-L., Yasui, Y., Ward, M. D., Cazares, L. H., Schellhammer, P. F., Feng, Z., Semmes, O. J., & Wright, G. L. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.10.1835 · Cited by 433
Voltz, R., Gultekin, S. H., Rosenfeld, M. R., Gerstner, E., Eichen, J., Posner, J. B., & Dalmau, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402303 · Cited by 379
Peptide and protein drug delivery to and into tumors: challenges and solutions
Torchilin, V. P., & Lukyanov, A. N. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02623-0 · Cited by 363
Pieper, R., Su, Q., Gatlin, C. L., Huang, S., Anderson, N. L., & Steiner, S. (2003) · PROTEOMICS · doi:10.1002/pmic.200390057 · Cited by 356
The thyroxine-binding proteins
Schussler, G. C. (2000) · Thyroid · doi:10.1089/thy.2000.10.141 · Cited by 329
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins
Rosenfeld, M. R., Eichen, J. G., Wade, D. F., Posner, J. B., & Dalmau, J. (2001) · Annals of Neurology · doi:10.1002/ana.1288 · Cited by 291
Dalmau, J., Gultekin, S. H., Voltz, R., Hoard, R., DesChamps, T., Balmaceda, C., Batchelor, T., Gerstner, E., Eichen, J., Frennier, J., et al. (1999) · Brain · doi:10.1093/brain/122.1.27 · Cited by 236
Biomarker Amplification by Serum Carrier Protein Binding
Mehta, A. I., Ross, S., Lowenthal, M. S., Fusaro, V., Fishman, D. A., Petricoin, E. F., & Liotta, L. A. (2003) · Disease Markers · doi:10.1155/2003/104879 · Cited by 208
Self-citationDown syndrome congenital heart disease: A narrowed region and a candidate gene
Barlow, G. M., Chen, X.-N., Shi, Z. Y., Lyons, G. E., Kurnit, D. M., Celle, L., Spinner, N. B., Zackai, E., Pettenati, M. J., Van Riper, A. J., et al. (2001) · Genetics in Medicine · doi:10.1097/00125817-200103000-00002 · Cited by 198
Peer Reviewed: SELDI-TOF MS for Diagnostic Proteomics
Issaq, H. J., Conrads, T. P., Prieto, D. A., Tirumalai, R., & D.Veenstra, T. (2003) · Analytical Chemistry · doi:10.1021/ac031249c · Cited by 188
Self-citationCancer diagnosis using proteomic patterns
Conrads, T. P., Zhou, M., III, E. F. P., Liotta, L., & Veenstra, T. D. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.4.411 · Cited by 164
Self-citationKennedy, S. (2002) · Biomarkers · doi:10.1080/13547500210127318 · Cited by 160
Tensin: A potential link between the cytoskeleton and signal transduction
Lo, S. H., Weisberg, E., & Chen, L. B. (1994) · BioEssays · doi:10.1002/bies.950161108 · Cited by 146
Clinical potential of proteomics in the diagnosis of ovarian cancer
Ardekani, A. M., Liotta, L. A., & Petricoin, E. F. (2002) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2.4.312 · Cited by 131
Self-citationAnalysis of the human serum proteome
Chan, K. C., Lucas, D. A., Hise, D., Schaefer, C. F., Xiao, Z., Janini, G. M., Buetow, K. H., Issaq, H. J., Veenstra, T. D., & Conrads, T. P. (2004) · Clinical Proteomics · doi:10.1385/cp:1:2:101 · Cited by 114
Self-citationBeyond Expansion: Structural Studies on the Transport Roles of Human Serum Albumin
Curry, S. (2002) · Vox Sanguinis · doi:10.1111/j.1423-0410.2002.tb05326.x · Cited by 113
SAFB2, a New Scaffold Attachment Factor Homolog and Estrogen Receptor Corepressor
Townson, S. M., Dobrzycka, K. M., Lee, A. V., Air, M., Deng, W., Kang, K., Jiang, S., Kioka, N., Michaelis, K., & Oesterreich, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212988200 · Cited by 96
Carboni, G. L., Gao, B., Nishizaki, M., Xu, K., Minna, J. D., Roth, J. A., & Ji, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206134 · Cited by 93
Disorders of Tetrahydrobiopterin Metabolism and their Treatment
Shintaku, H. (2002) · Current Drug Metabolism · doi:10.2174/1389200024605145 · Cited by 91
Albumin Binding of Acylated Insulin (NN304) Does Not Deter Action to Stimulate Glucose Uptake
Dea, M. K., Hamilton-Wessler, M., Ader, M., Moore, D., Schäffer, L., Loftager, M., Vølund, A., & Bergman, R. N. (2002) · Diabetes · doi:10.2337/diabetes.51.3.762 · Cited by 70
Awad, S. S., Lamb, H. K., Morgan, J. M., Dunlop, W., & Gillespie, J. (1997) · Biochemical Journal · doi:10.1042/bj3220777 · Cited by 54
BENN, P. A. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00187-0 · Cited by 50
Basso, D., Valerio, A., Brigato, L., Panozzo, M. P., Miola, M., Lucca, T., Ujka, F., Zaninotto, M., Avogaro, A., & Plebani, M. (1997) · Pancreas · doi:10.1097/00006676-199708000-00004 · Cited by 39
MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies
Comtesse, N., Niedermayer, I., Glass, B., Heckel, D., Maldener, E., Nastainczyk, W., Feiden, W., & Meese, E. U. (2002) · Oncogene · doi:10.1038/sj.onc.1205005 · Cited by 31
RBT1, a novel transcriptional co-activator, binds the second subunit of Replication Protein A
Cho, J. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3478 · Cited by 26
Pax-2 interacts with RB and reverses its repression on the promoter of Rig-1, a Robo member
Yuan, S. F., Yeh, Y., & Lee, E. Y.-H. P. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02032-6 · Cited by 23
Glycosylasparaginase as a Marker Enzyme in the Detection of I-Cell Disease
Ylikangas, P., & Mononen, I. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2543 · Cited by 2
Cited by
Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500358 · Cited by 787
Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics
Tu, C., Rudnick, P. A., Martinez, M. Y., Cheek, K. L., Stein, S. E., Slebos, R. J. C., & Liebler, D. C. (2010) · Journal of Proteome Research · doi:10.1021/pr100646w · Cited by 390
The blood peptidome: a higher dimension of information content for cancer biomarker discovery
Petricoin, E. F., Belluco, C., Araujo, R. P., & Liotta, L. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2011 · Cited by 357
Self-citationApplication of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review
Jin, C., Wang, K., Oppong-Gyebi, A., & Hu, J. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.49801 · Cited by 353
States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D., Eng, J., Speicher, D. W., & Hanash, S. M. (2006) · Nature Biotechnology · doi:10.1038/nbt1183 · Cited by 325
Metadata
- Authors
- Zhou, M., Lucas, D. A., Chan, K. C., Issaq, H. J., Petricoin, E. F., Liotta, L. A., Veenstra, T. D., & Conrads, T. P.
- Venue
- ELECTROPHORESIS
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 25
- Issue
- 9
- Pages
- 1289-1298
- ISSN
- 0173-0835 (ISSN-L)
- 1522-2683
- OpenAlex
- W1992730111
- Cited by
- 313
- References
- 36
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.